Managing the complexity of multiple sclerosis

被引：0
|
作者：
Olga Ciccarelli
Alan Thompson
机构：
[1] Queen Square Multiple Sclerosis Centre,
[2] University College London Institute of Neurology and National Institute for Health Research UCL Hospitals–UCL Biomedical Research Centre,undefined
来源：
Nature Reviews Neurology | 2016年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The application of imaging biomarkers has provided new insights into the mechanisms of damage in multiple sclerosis (MS) and the risk of MS development and progression. The goal of eliminating all disease activity requires a timely escalation of treatment. This increasing complexity is compounded by the need to treat comorbidities.
引用
收藏
页码：70 / 72
页数：2
相关论文
共 50 条
  • [11] Managed Care Aspects of Managing Multiple Sclerosis
    Mathis, A. Scott
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2013, 19 (02): : S28 - S34
  • [12] Cost of managing relapses in patients with multiple sclerosis
    Rao, S
    Yu, H
    [J]. ANNALS OF NEUROLOGY, 2004, 56 : S2 - S2
  • [13] On receiving the diagnosis of multiple sclerosis: managing the transition
    Johnson, J
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (01) : 82 - 88
  • [14] Managed Care Aspects of Managing Multiple Sclerosis
    Owens, Gary M.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2013, 19 (16): : S307 - S312
  • [15] Pharmacotherapeutic Options for Managing Pain in Multiple Sclerosis
    Di Stefano, Giulia
    De Stefano, Gianfranco
    Di Lionardo, Andrea
    Cruccu, Giorgio
    Truini, Andrea
    [J]. CNS DRUGS, 2020, 34 (07) : 749 - 761
  • [16] A multimodal approach to managing the symptoms of multiple sclerosis
    Crayton, H
    Heyman, RA
    Rossman, HS
    [J]. NEUROLOGY, 2004, 63 (11) : S12 - S18
  • [17] Managing the symptoms of multiple sclerosis: A multimodal approach
    Crayton, Heidi J.
    Rossman, Howard S.
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (04) : 445 - 460
  • [18] Pharmacotherapeutic Options for Managing Pain in Multiple Sclerosis
    Giulia Di Stefano
    Gianfranco De Stefano
    Andrea Di Lionardo
    Giorgio Cruccu
    Andrea Truini
    [J]. CNS Drugs, 2020, 34 : 749 - 761
  • [19] Managing Risks with Immune Therapies in Multiple Sclerosis
    Foerster, Moritz
    Kuery, Patrick
    Aktas, Orhan
    Warnke, Clemens
    Havla, Joachim
    Hohlfeld, Reinhard
    Mares, Jan
    Hartung, Hans-Peter
    Kremer, David
    [J]. DRUG SAFETY, 2019, 42 (05) : 633 - 647
  • [20] Managing Risks with Immune Therapies in Multiple Sclerosis
    Moritz Förster
    Patrick Küry
    Orhan Aktas
    Clemens Warnke
    Joachim Havla
    Reinhard Hohlfeld
    Jan Mares
    Hans-Peter Hartung
    David Kremer
    [J]. Drug Safety, 2019, 42 : 633 - 647
12345